Cargando…
Nivolumab maintenance in high-risk acute myeloid leukemia patients: a single-arm, open-label, phase II study
| Autores principales: | , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7969746/ https://www.ncbi.nlm.nih.gov/pubmed/33731681 http://dx.doi.org/10.1038/s41408-021-00453-z |
| _version_ | 1783666288705404928 |
|---|---|
| author | Reville, Patrick K. Kantarjian, Hagop M. Ravandi, Farhad Jabbour, Elias DiNardo, Courtney D. Daver, Naval Pemmaraju, Naveen Ohanian, Maro Alvarado, Yesid Xiao, Lianchun Alatrash, Gheath Loghavi, Sanam Rausch, Caitlin R. Borthakur, Gautam Konopleva, Marina Cortes, Jorge Kadia, Tapan M. |
| author_facet | Reville, Patrick K. Kantarjian, Hagop M. Ravandi, Farhad Jabbour, Elias DiNardo, Courtney D. Daver, Naval Pemmaraju, Naveen Ohanian, Maro Alvarado, Yesid Xiao, Lianchun Alatrash, Gheath Loghavi, Sanam Rausch, Caitlin R. Borthakur, Gautam Konopleva, Marina Cortes, Jorge Kadia, Tapan M. |
| author_sort | Reville, Patrick K. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7969746 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Nature Publishing Group UK |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-79697462021-04-12 Nivolumab maintenance in high-risk acute myeloid leukemia patients: a single-arm, open-label, phase II study Reville, Patrick K. Kantarjian, Hagop M. Ravandi, Farhad Jabbour, Elias DiNardo, Courtney D. Daver, Naval Pemmaraju, Naveen Ohanian, Maro Alvarado, Yesid Xiao, Lianchun Alatrash, Gheath Loghavi, Sanam Rausch, Caitlin R. Borthakur, Gautam Konopleva, Marina Cortes, Jorge Kadia, Tapan M. Blood Cancer J Correspondence Nature Publishing Group UK 2021-03-17 /pmc/articles/PMC7969746/ /pubmed/33731681 http://dx.doi.org/10.1038/s41408-021-00453-z Text en © The Author(s) 2021 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/. |
| spellingShingle | Correspondence Reville, Patrick K. Kantarjian, Hagop M. Ravandi, Farhad Jabbour, Elias DiNardo, Courtney D. Daver, Naval Pemmaraju, Naveen Ohanian, Maro Alvarado, Yesid Xiao, Lianchun Alatrash, Gheath Loghavi, Sanam Rausch, Caitlin R. Borthakur, Gautam Konopleva, Marina Cortes, Jorge Kadia, Tapan M. Nivolumab maintenance in high-risk acute myeloid leukemia patients: a single-arm, open-label, phase II study |
| title | Nivolumab maintenance in high-risk acute myeloid leukemia patients: a single-arm, open-label, phase II study |
| title_full | Nivolumab maintenance in high-risk acute myeloid leukemia patients: a single-arm, open-label, phase II study |
| title_fullStr | Nivolumab maintenance in high-risk acute myeloid leukemia patients: a single-arm, open-label, phase II study |
| title_full_unstemmed | Nivolumab maintenance in high-risk acute myeloid leukemia patients: a single-arm, open-label, phase II study |
| title_short | Nivolumab maintenance in high-risk acute myeloid leukemia patients: a single-arm, open-label, phase II study |
| title_sort | nivolumab maintenance in high-risk acute myeloid leukemia patients: a single-arm, open-label, phase ii study |
| topic | Correspondence |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7969746/ https://www.ncbi.nlm.nih.gov/pubmed/33731681 http://dx.doi.org/10.1038/s41408-021-00453-z |
| work_keys_str_mv | AT revillepatrickk nivolumabmaintenanceinhighriskacutemyeloidleukemiapatientsasinglearmopenlabelphaseiistudy AT kantarjianhagopm nivolumabmaintenanceinhighriskacutemyeloidleukemiapatientsasinglearmopenlabelphaseiistudy AT ravandifarhad nivolumabmaintenanceinhighriskacutemyeloidleukemiapatientsasinglearmopenlabelphaseiistudy AT jabbourelias nivolumabmaintenanceinhighriskacutemyeloidleukemiapatientsasinglearmopenlabelphaseiistudy AT dinardocourtneyd nivolumabmaintenanceinhighriskacutemyeloidleukemiapatientsasinglearmopenlabelphaseiistudy AT davernaval nivolumabmaintenanceinhighriskacutemyeloidleukemiapatientsasinglearmopenlabelphaseiistudy AT pemmarajunaveen nivolumabmaintenanceinhighriskacutemyeloidleukemiapatientsasinglearmopenlabelphaseiistudy AT ohanianmaro nivolumabmaintenanceinhighriskacutemyeloidleukemiapatientsasinglearmopenlabelphaseiistudy AT alvaradoyesid nivolumabmaintenanceinhighriskacutemyeloidleukemiapatientsasinglearmopenlabelphaseiistudy AT xiaolianchun nivolumabmaintenanceinhighriskacutemyeloidleukemiapatientsasinglearmopenlabelphaseiistudy AT alatrashgheath nivolumabmaintenanceinhighriskacutemyeloidleukemiapatientsasinglearmopenlabelphaseiistudy AT loghavisanam nivolumabmaintenanceinhighriskacutemyeloidleukemiapatientsasinglearmopenlabelphaseiistudy AT rauschcaitlinr nivolumabmaintenanceinhighriskacutemyeloidleukemiapatientsasinglearmopenlabelphaseiistudy AT borthakurgautam nivolumabmaintenanceinhighriskacutemyeloidleukemiapatientsasinglearmopenlabelphaseiistudy AT konoplevamarina nivolumabmaintenanceinhighriskacutemyeloidleukemiapatientsasinglearmopenlabelphaseiistudy AT cortesjorge nivolumabmaintenanceinhighriskacutemyeloidleukemiapatientsasinglearmopenlabelphaseiistudy AT kadiatapanm nivolumabmaintenanceinhighriskacutemyeloidleukemiapatientsasinglearmopenlabelphaseiistudy |